Published on in Vol 10, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/21256, first published .
Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)

Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)

Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)

Vincent Pluimakers   1 , MD ;   Marta Fiocco   1, 2, 3 , PhD ;   Jenneke van Atteveld   1 , MD ;   Monique Hobbelink   4 , MD ;   Dorine Bresters   1 , MD, PhD ;   Eline Van Dulmen-den Broeder   1, 5 , PhD ;   Margriet Van der Heiden-van der Loo   6 , PhD ;   Geert O Janssens   1, 4 , MD, PhD ;   Leontien Kremer   1, 5 , MD ;   Jacqueline Loonen   7 , MD, PhD ;   Marloes Louwerens   2 , MD ;   Helena Van der Pal   1 , MD, PhD ;   Cécile Ronckers   1, 5, 8 , PhD ;   Hanneke Van Santen   1, 9 , MD, PhD ;   Birgitta Versluys   1, 9 , MD, PhD ;   Andrica De Vries   1, 10 , MD, PhD ;   Marry Van den Heuvel-Eibrink   1 , MD ;   Sebastian Neggers   1, 11 , MD, PhD

1 Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

2 Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands

3 Mathematical Institute, Leiden University, Leiden, Netherlands

4 Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands

5 Department of Pediatric Oncology, Emma Children’s Hospital/Amsterdam University Medical Center, Amsterdam, Netherlands

6 Dutch Childhood Oncology Group, Utrecht, Netherlands

7 Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands

8 Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany

9 Department of Pediatric Oncology and Hematology, Wilhelmina Children’s Hospital/University Medical Center Utrecht, Utrecht, Netherlands

10 Department of Pediatric Oncology/Hematology, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, Netherlands

11 Department of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands

Corresponding Author: